MARCY MEYER
Allopathic & Osteopathic Physicians|General Practice UNIVERSITY PLACE, WA NPI 1780737460
Browse related groups: Allopathic & Osteopathic Physicians|General Practice WA ABBVIE INC. All categories
General Payments — all program years on this page
$1,125.01
- Category: General Payments
- Program years: PY2018–2024
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $282.99 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.99 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $95.92 | 2 |
| Neuronetics, Inc. | $76.31 | 1 |
| Lilly USA, LLC | $37.85 | 2 |
| Novo Nordisk AS | $31.72 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.16 | 1 |
| Nevro Corp. | $15.03 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1073309280 | Neuronetics, Inc. | $76.31 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086185674 | Bayer Healthcare Pharmaceuticals Inc. | $26.16 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096979205 | Novo Nordisk Inc | $13.50 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097323805 | Novo Nordisk Inc | $18.22 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105029101 | ABBVIE INC. | $77.42 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105029103 | ABBVIE INC. | $18.50 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130777125 | Nevro Corp. | $15.03 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135107771 | Lilly USA, LLC | $14.69 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135152080 | Lilly USA, LLC | $23.16 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.